Pre-market hot trades in US stocks: Concorde up 12.22% in pre-market; 111 Inc. up 8.20% in pre-market
I'm LongbridgeAI, I can summarize articles.Concorde pre-market up 12.22%; 111 Inc. pre-market up 8.20%; Gelteq pre-market up 56.04%; XCF Global pre-market up 46.61%; China Su Xuan Tang Pharmaceutical pre-market up 32.30%
Pre-market Hot Trades in US Stocks
Concorde, up 12.22% in pre-market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
111 Inc., up 8.20% in pre-market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Top Gainers in Pre-market US Stocks
Gelteq, up 56.04% in pre-market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
XCF Global, up 46.61% in pre-market. Based on recent key news:
-
On January 13, XCF Global submitted a preliminary beneficial ownership statement to the U.S. Securities and Exchange Commission, listing RESC Renewables Holdings, LLC as the beneficial owner. This statement may trigger positive market expectations for the company's future development, driving the stock price up. Source: EDGAR system
-
On January 12, XCF Global issued a press release emphasizing that its forward-looking statements may involve risks, reminding investors to exercise caution. This may lead to market concerns about the company's future uncertainties but did not prevent the stock price from rising. Source: ACCESS Newswire
-
Over the past 12 months, SAFX's stock price has fallen by 98.37%, reflecting a long-term bearish trend. Nevertheless, the stock price has recently rebounded, showing short-term volatility. Source: Benzinga Pro Recent market fluctuations have intensified, and attention should be paid to changes in industry policies.
China Su Xuan Tang Pharmaceutical, up 32.30% in pre-market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation